» Articles » PMID: 29222581

Fractures in Children with Newly Diagnosed Hepatoblastoma

Overview
Journal Pediatr Radiol
Specialty Pediatrics
Date 2017 Dec 10
PMID 29222581
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatoblastoma is the most common primary hepatic malignancy in children. We have recently noticed an increased incidence of unsuspected fractures in children with newly diagnosed hepatoblastoma. This association has been suggested in the past, but the incidence and pathophysiology remain uncertain.

Objective: To define the incidence and imaging features of fractures in children with newly diagnosed hepatoblastoma.

Materials And Methods: We searched the oncology database and the radiology picture archiving and communication system of our large tertiary care children's hospital between January 2000 and August 2013 for all patients who presented to our institution with newly diagnosed hepatoblastoma. We reviewed all available imaging exams (radiographs, CT scans, MRIs, and nuclear medicine studies) to identify children who had radiologically apparent fractures on exams during the 50 days prior to diagnosis or up to 2 weeks after the date of hepatoblastoma diagnosis.

Results: Forty-five children were included in this retrospective study. Eight children (17.8%) had fractures within 50 days prior to diagnosis or up to 2 weeks after the date of diagnosis, with a mean number of 4.9 fractures per patient (range 1-13). Only 21 of the 39 fractures (54%) were diagnosed during the initial image interpretation. Fractures most commonly occurred in the ribs (n=21) and vertebral bodies (n=10). The presence of a fracture was not associated with an identified demographic, tumor or laboratory finding.

Conclusion: Unsuspected fractures are relatively common in children with newly diagnosed hepatoblastoma.

Citing Articles

Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part I.

Dong Y, Cekuolis A, Schreiber-Dietrich D, Augustiniene R, Schwarz S, Moller K Diagnostics (Basel). 2023; 13(23).

PMID: 38066809 PMC: 10706220. DOI: 10.3390/diagnostics13233568.


Update on the Pathology of Pediatric Liver Tumors: A Pictorial Review.

Bhagat P, Vij M, Raju L, Gowrishankar G, Menon J, Shanmugam N Diagnostics (Basel). 2023; 13(23).

PMID: 38066766 PMC: 10706829. DOI: 10.3390/diagnostics13233524.


Multiple Fractures in an Infant With Hepatoblastoma and Beckwith-Wiedemann Syndrome.

Eimicke T, Swartz J JCEM Case Rep. 2023; 1(5):luad110.

PMID: 37908208 PMC: 10612471. DOI: 10.1210/jcemcr/luad110.


Bone metastases in hepatoblastoma, an unusual presentation. Case report and review of the literature.

Barragan V, Escudero M, Jimenez I, Correa C, Luengas J Radiol Case Rep. 2022; 17(11):4272-4275.

PMID: 36124317 PMC: 9482079. DOI: 10.1016/j.radcr.2022.08.025.


Treatment outcomes for hepatoblastoma children with pulmonary metastasis and extrapulmonary involvement: experience of 36 cases at a single institution.

Hu H, Zhang W, Wang Y, Zhang Y, Yi Y, Li F Transl Cancer Res. 2022; 9(10):6402-6411.

PMID: 35117248 PMC: 8798061. DOI: 10.21037/tcr-20-1876.


References
1.
Moritake H, Taketomi A, Kamimura S, Ikuno Y, Seo Y, Fukuda T . Renin-producing hepatoblastoma. J Pediatr Hematol Oncol. 2000; 22(1):78-80. DOI: 10.1097/00043426-200001000-00015. View

2.
Archer D, Babyn P, Gilday D, Greenberg M . Potentially misleading bone scan findings in patients with hepatoblastoma. Clin Nucl Med. 1993; 18(12):1026-31. DOI: 10.1097/00003072-199312000-00004. View

3.
Pugmire B, Towbin A . Magnetic resonance imaging of primary pediatric liver tumors. Pediatr Radiol. 2016; 46(6):764-77. DOI: 10.1007/s00247-016-3612-0. View

4.
TENG C, DAESCHNER Jr C, Singleton E, Rosenberg H, COLE V, Hill L . Liver diseases and osteoporosis in children. I. Clinical observations. J Pediatr. 1961; 59:684-702. DOI: 10.1016/s0022-3476(61)80005-x. View

5.
Meyers R, Maibach R, Hiyama E, Haberle B, Krailo M, Rangaswami A . Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Lancet Oncol. 2016; 18(1):122-131. PMC: 5650231. DOI: 10.1016/S1470-2045(16)30598-8. View